GoodRx Holdings annual return on equity
2021
2022
2023
2024
2025
GoodRx Holdings Return on Equity (ROE) Growth & History (GDRX)
GoodRx Holdings's return on equity was 4.54% for fiscal 2025.
View full GoodRx Holdings company overviewGoodRx Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 4.54% | +2.34 pp |
| 2024 | 2024-12-31 | 2.21% | +3.33 pp |
| 2023 | 2023-12-31 | −1.12% | +2.86 pp |
| 2022 | 2022-12-31 | −3.99% | −0.71 pp |
| 2021 | 2021-12-31 | −3.27% | — |
GoodRx Holdings quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.34% | −0.64 pp |
| Q1 2026 | 2026-03-31 | 0.19% | −1.41 pp |
| Q4 2025 | 2025-12-31 | 0.89% | −0.06 pp |
| Q3 2025 | 2025-09-30 | 0.18% | −0.40 pp |
| Q2 2025 | 2025-06-30 | 1.98% | +0.95 pp |
| Q1 2025 | 2025-03-31 | 1.60% | +1.75 pp |
| Q4 2024 | 2024-12-31 | 0.95% | +4.10 pp |
| Q3 2024 | 2024-09-30 | 0.58% | +4.91 pp |
| Q2 2024 | 2024-06-30 | 1.03% | −5.79 pp |
| Q1 2024 | 2024-03-31 | −0.14% | +0.26 pp |
| Q4 2023 | 2023-12-31 | −3.15% | −2.90 pp |
| Q3 2023 | 2023-09-30 | −4.33% | +0.86 pp |
| Q2 2023 | 2023-06-30 | 6.82% | +7.00 pp |
| Q1 2023 | 2023-03-31 | −0.40% | −1.92 pp |
| Q4 2022 | 2022-12-31 | −0.25% | +4.51 pp |
| Q3 2022 | 2022-09-30 | −5.20% | −3.03 pp |
| Q2 2022 | 2022-06-30 | −0.18% | −4.12 pp |
| Q1 2022 | 2022-03-31 | 1.52% | +1.29 pp |
| Q4 2021 | 2021-12-31 | −4.76% | +35.89 pp |
| Q3 2021 | 2021-09-30 | −2.16% | — |
| Q2 2021 | 2021-06-30 | 3.95% | — |
| Q1 2021 | 2021-03-31 | 0.23% | — |
| Q4 2020 | 2020-12-31 | −40.64% | — |
GoodRx Holdings return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, GoodRx Holdings's return on equity increased from −3.27% to 4.54%, a change of +7.81 percentage points. The latest reported quarter, Q2 2026, shows 1.34%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GoodRx Holdings source filings ↗